Glioblastoma Multiforme (GBM) Therapeutics Market: Latest Developments and Future Directions
Glioblastoma Multiforme (GBM), one of the most aggressive brain cancers, remains a significant challenge in oncology due to its complexity and resistance to conventional treatments. The GBM therapeutics market is … Read More